Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: $5/day · orange-and-blue alternate. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
This ad puts a real number on screen, and it frames it well: $5/day is big and bright, with the monthly figure underneath for anyone who wants the full picture. A daily number is easy to compare with things people already spend money on, which makes the price feel graspable. The pill held up to the sky shows the product at a glance. Ro started running it on Meta on October 2, 2026, and it sends people to the same quiz as the rest of the campaign.
The primary text doesn't mention the price at all. It's the generic access-to-GLP-1s copy used across Ro's ads, so anyone who reads the text instead of the image misses the whole point. The fine print also notes that membership is separate, which the image doesn't explain. If you make one like this, repeat the price in the first line of the copy and say plainly what the number includes, so the hook survives every placement.
It shows the product as something light and everyday, without needing a person in the shot.
Breaking the price into a daily number makes it easy to compare with everyday spending.
It explains the next step, though it leaves the price hook to the image alone.
Advertised medication starting at $5/day or $149/month, framed as a daily figure first. The ad notes that ongoing membership is separate.
The click lands on Ro's weight-loss quiz entry, which the persona's landing-page ladder puts above a homepage or a basic product page. The page opens with the headline Lose weight on Ro, a photo of Serena Williams labeled as a Ro member, and a card asking which Ro option you're interested in (GLP-1 pill, GLP-1 shot, learn about both, or a provider recommendation), with a banner up top claiming the lowest GLP-1 prices are on Ro. The banner's lowest-price line is a reasonable echo of a price ad, but the captured page doesn't repeat the $5/day figure, so the number that earned the click isn't confirmed on arrival. Putting the price next to the first question would close that gap.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.